# CLINICAL PROTOCOL to Investigate the Long-term Safety and Efficacy of Metreleptin in Various Forms of Partial Lipodystrophy

> **NCT02654977** · PHASE2 · COMPLETED · sponsor: **University of Michigan** · enrollment: 11 (actual)

## Conditions studied

- Familial Partial Lipodystrophy
- Nonalcoholic Steatohepatitis
- NAFLD

## Interventions

- **DRUG:** Metreleptin

## Key facts

- **NCT ID:** NCT02654977
- **Lead sponsor:** University of Michigan
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09-29
- **Primary completion:** 2019-11-14
- **Final completion:** 2019-11-14
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2020-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02654977

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02654977, "CLINICAL PROTOCOL to Investigate the Long-term Safety and Efficacy of Metreleptin in Various Forms of Partial Lipodystrophy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02654977. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*